These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11151060)

  • 1. Molecular characterization of colorectal neoplasia in translational research.
    Grizzle WE; Manne U; Jhala NC; Weiss HL
    Arch Pathol Lab Med; 2001 Jan; 125(1):91-8. PubMed ID: 11151060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
    Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between p53 expression and Bcl-2, P-glycoprotein, topoisomerase II alpha, thymidylate synthase and thymidine phosphorylase as potential therapeutic targets in colorectal cancer patients.
    Bidgoli SA; Azizi E; Zavarhei MD
    Pak J Biol Sci; 2007 Oct; 10(19):3350-5. PubMed ID: 19090149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do young patients with colorectal cancer have a poorer prognosis than old patients?
    Li M; Li JY; Zhao AL; Gu J
    J Surg Res; 2011 May; 167(2):231-6. PubMed ID: 21316708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
    Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
    Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen.
    Veisi Malekshahi Z; Amani J; Negahdari B; Rajabibazl M; Ebrahimizadeh W
    J Cell Biochem; 2018 Apr; 119(4):3464-3473. PubMed ID: 29144000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
    Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
    Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.
    Tiernan JP; Perry SL; Verghese ET; West NP; Yeluri S; Jayne DG; Hughes TA
    Br J Cancer; 2013 Feb; 108(3):662-7. PubMed ID: 23322207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.
    Mahvi DM; Madsen JA; Witt PL; Sondel PM
    Cancer Immunol Immunother; 1995 May; 40(5):311-4. PubMed ID: 7600563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
    Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
    Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.